The percentage on each card is MLTX's move today, from the quote feed. It is the same figure on every headline, not the move on that headline's own date.
● GlobeNewsWireNov 4, 2026 · 07:00 ETCOMPANY'S OWN WORDS
MoonLake Reports Third Quarter 2026 Financial Results and Provides a Business Update
ZUG, Switzerland, November 4, 2026 – MoonLake Immunotherapeutics (NASDAQ: MLTX) ("MoonLake" or the "Company"), a clinical-stage biotechnology company focused on creating next-level therapies for inflammatory diseases, to…
What's Going On with MoonLake Immunotherapeutics Stock on Thursday?
MoonLake Immunotherapeutics (NASDAQ:MLTX) stock is trading higher on Thursday with a session volume of 4.20 million compared to the average volume of 1.494 million, according to Benzinga Pro data.…
MoonLake Immunotherapeutics: The Bull Case Does Not Require Clinical Supremacy
MoonLake Immunotherapeutics offers a compelling investment case despite sonelokimab's mixed clinical results, focusing on regulatory progress and commercial viability. MLTX can file for HS approval without another major …
Article counts from the last market-wide feed page, across every symbol we track and not just MLTX · day move from the quote feed. Equal counts are listed alphabetically, not ranked. Coverage ≠ importance.
The feed is purely chronological. No materiality ranking, no hidden sentiment score. Timestamps are publisher-reported and arrive with no timezone, so they are read and shown on the US market clock (ET); thumbnails come from each article's image field; day moves from the quote feed. Copies of the same story are collapsed on link or normalized headline, and a company's press release is kept over any syndicated copy of it; "company's own words" means the release title leads with the company's name and the wire names no other organisation first as its issuer; "earnings-tied" is a keyword match while a report date is upcoming. Not investment advice.